Qing Yi, M.D., Ph.D.
The Methodist Hospital Research Institute
|Titles & Positions|
|Institutional & Related Links|
|Grant ID: RR180044|
Recruitment of Established Investigators
Lerner Research Institute - Cleveland Clinic
May 16, 2018
Qing Yi, MD, PhD, is the Associate Director for Basic Research at Houston Methodist Cancer Center and the Director of the Houston Methodist Center for Translational Research in Hematological Malignancies. Dr. Yi is one of the leading investigators in the field of immune regulation and immunotherapy in multiple myeloma (MM). He has been working on tumor immunology and immunotherapy in MM for more than 25 years. Dr. Yi and his group have been generating novel monoclonal antibodies (mAbs) to treat patients with MM and other cancers. His research continues to focus on the development of effective immunotherapy strategies to cure myeloma patients in combination with high dose chemotherapy. Dr. Yi's research has been supported by U.S. federal and foundation grants since 1998, and he has authored more than 160 papers in the fields of myeloma research, immunotherapy of cancer, and tumor biology.